MASSO ROJAS, FELIPE ALONSO

MASSO ROJAS, FELIPE ALONSO

INVESTIGACIÓN MÉDICA · Nivel 1

Información*

Nombre FELIPE ALONSO MASSO ROJAS
Área MEDICINA Y CIENCIAS DE LA SALUD
Campo INVESTIGACIÓN MÉDICA
Disciplina CARDIOLOGÍA, FISIOLOGÍA CARDIOVASCULAR
Especialidad MEDICINA TRASLACIONAL
CVU 11437
Institución
Dependencia SIN INFORMACIÓN
Entidad CIUDAD DE MEXICO
Nivel 1
Vigencia Inicio: 01/01/2021
Fin: 31/12/2039
Categoría: EXTENSION 15 AÑOS

* Información del primer trimestre de 2026.
Fuente: SECIHTI.

Publicaciones ORCID

2026
Serum from Antiphospholipid Syndrome Patients Downregulates Endothelial lncRNAs HIF1A-AS1 and OIP5-AS1 International Journal of Molecular Sciences
2025
GDF11 induces chemosensitization in human hepatocellular carcinoma cells by decreasing drug-efflux transporters Exploration of Digestive Diseases
Effect of Platelet-Derived Microparticles on the Expression of Adhesion Molecules in Endothelial Cells International Journal of Molecular Sciences
Influence of menopause status on T-helper cell profiles in acute myocardial infarction Biomolecules and Biomedicine
2024
KS-WNK1 is required for the renal response to extreme changes in potassium intake American Journal of Physiology-Renal Physiology
2023
Nitrogen-Containing Bisphosphonates Downregulate Cathepsin K and Upregulate Annexin V in Osteoclasts Cultured In Vitro International Journal of Dentistry
2022
The hepatocyte growth factor induces an anti-inflammatory and repairing response in the cholestasis-induced colon damage Exploration of Digestive Diseases
2021
Effectiveness and Safety of Extracorporeal Shockwave Myocardial Revascularization in Patients With Refractory Angina Pectoris and Heart Failure The American Journal of Cardiology
Role of the Transient Receptor Potential Vanilloid Type 1 (TRPV1) in the Regulation of Nitric Oxide Release in Wistar Rat Aorta Oxidative Medicine and Cellular Longevity
2019
Improved Efficiency of Cardiomyocyte-Like Cell Differentiation from Rat Adipose Tissue-Derived Mesenchymal Stem Cells with a Directed Differentiation Protocol Stem Cells International